Impact of comorbidities on mortality in hospitalized patients with COVID-19: An experience from Iran

被引:6
|
作者
Toofan, Firooz [1 ]
Hosseini, Seyed Mojtaba [1 ]
Alimohammadzadeh, Khalil [1 ,2 ]
Jafari, Mehrnoosh [1 ]
Bahadori, Mohammadkarim [3 ]
机构
[1] Islamic Azad Univ, Dept Hlth Serv Management, North Tehran Branch, Tehran, Iran
[2] Islamic Azad Univ, Tehran Med Sci Branch, Hlth Econ Policy Res Ctr, Tehran, Iran
[3] Baqiyatallah Univ Med Sci, Hlth Management Res Ctr, Tehran, Iran
关键词
Comorbidity; Iran; mortality; multimorbidity; SARS-CoV-2; MULTIMORBIDITY; OUTCOMES; CITY;
D O I
10.4103/jehp.jehp_1589_20
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
BACKGROUND: COVID-19 pandemic has spread all over the world. However, information regarding clinical characteristics and prognostic factors is scarce. The aim of this study was to explore the impact of preexistent chronic comorbid conditions and multimorbidity on risk of mortality in patients with COVID-19.MATERIALS AND METHODS: We designed a retrospective, cross-sectional, observational, single-center study. Data were analyzed from all consecutive patients diagnosed with COVID-19 who admitted in a pandemic hospital affiliated with Tabriz University of Medical Sciences, Tabriz, Iran, from February 20, 2020, to September 25, 2020. The independent effects of preexistent conditions were evaluated using multivariate logistic regression model.RESULTS: A total of 2597 hospitalized patients with COVID-19 were included. At least one preexistent condition was observed in 36.5% of study population. Multivariate logistic regression analysis showed that older age, male sex, diabetes, cardiovascular disease, hypertension, cancer, chronic kidney diseases, liver diseases, and chronic obstructive pulmonary disease were associated with increased risk of mortality. In addition, the number of comorbidities was significantly associated with increased odds of mortality compared to no-comorbidity.CONCLUSION: The results of this study suggest that patients with comorbidities have an increased risk of in-hospital mortality following COVID-19 infection.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Comorbidities associated with mortality or devere disease in hospitalized patients with COVID-19
    Carmen Gayol-Fernandez, M.
    Carmen Beceiro-Abad, M.
    Pazo-Nunez, Maria
    Mateo-Mosquera, Lara M.
    Paez-Guillan, Emilio
    Freire-Romero, M. Aurora
    Taboada-Muniz, Manuel
    Molinos-Castro, Sonia
    GALICIA CLINICA, 2022, 83 (03): : 18 - 27
  • [2] COVID-19 Mortality and Related Comorbidities in Hospitalized Patients in Bulgaria
    Dimova, Rositsa
    Stoyanova, Rumyana
    Blagoeva, Vesela
    Mavrov, Momchil
    Doykov, Mladen
    HEALTHCARE, 2022, 10 (08)
  • [3] Comorbidities and mortality in COVID-19 patients
    Djaharuddin, Irawaty
    Munawwarah, Sitti
    Nurulita, Asvin
    Ilyas, Muh
    Tabri, Nur Ahmad
    Lihawa, Nurjannah
    GACETA SANITARIA, 2021, 35 : S530 - S532
  • [4] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Alqahtani, Saad M. A.
    Al Saglan, Naif S.
    AlShehry, Ali A.
    Hawan, Ali
    Dafalla, Badraltamam A. A.
    Mohamed, Nahid A. S.
    Kadasah, Ali S.
    Qureshi, Muhammad A.
    Al-Shahrani, Nourah A.
    Alfaifi, Abdulaziz S. Y.
    Alqahtani, Mohammed A.
    Alshafa, Fawwaz A.
    Alsalem, Ali A.
    Al-Imamah, Yahya A.
    Abdullah, Alahmari
    Alzulfah, Saad A. S.
    Mahmoud, Ibrahim M. A.
    Abuelhassan, Usama E.
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2023, 17 (01)
  • [5] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Saad M. A. alqahtani
    Naif S. Al Saglan
    Ali A. AlShehry
    Ali Hawan
    Badraltamam A. A.Dafalla
    Nahid A. S. Mohamed
    Ali S. Kadasah
    Muhammad A.Qureshi
    Nourah A. Al-Shahrani
    Abdulaziz S. Y. Alfaifi
    Mohammed A. Alqahtani
    Fawwaz A. Alshafa
    Ali A. Alsalem
    Yahya A. Al-Imamah
    Alahmari Abdullah
    Saad A. S. Alzulfah
    Ibrahim M. A. Mahmoud
    Usama E. Abuelhassan
    The Egyptian Journal of Bronchology, 17
  • [6] Impact of comorbidities and inflammatory markers on mortality of COVID-19 patients
    Karim, Azmat
    Shameem, Mohammad
    Talwar, Anjana
    Talwar, Deepak
    LUNG INDIA, 2024, 41 (01) : 40 - 46
  • [7] Prevalence of Comorbidities and its Impacts in Hospitalized Patients with COVID-19
    Khaksar, Mohammad Ali
    Yousefabadi, Elham Zanganeh
    Zadeh, Reza Taleb
    Rashidi, Homeira
    Maniati, Mahmood
    Bakhtiari, Nima
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2021, 7 (05): : 295 - 302
  • [8] Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
    Kang, Min-Kyu
    Lee, Yu-Rim
    Song, Jeung-Eun
    Kweon, Young-Oh
    Tak, Won-Young
    Jang, Se-Young
    Park, Jung-Gil
    Park, Soo-Young
    DIAGNOSTICS, 2022, 12 (09)
  • [9] The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19
    Stepanova, Maria
    Lam, Brian
    Younossi, Elena
    Felix, Sean
    Ziayee, Mariam
    Price, Jillian
    Pham, Huong
    de Avila, Leyla
    Terra, Kathy
    Austin, Patrick
    Jeffers, Thomas
    Escheik, Carey
    Golabi, Pegah
    Cable, Rebecca
    Srishord, Manirath
    Venkatesan, Chapy
    Henry, Linda
    Gerber, Lynn
    Younossi, Zobair M.
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [10] The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19
    Maria Stepanova
    Brian Lam
    Elena Younossi
    Sean Felix
    Mariam Ziayee
    Jillian Price
    Huong Pham
    Leyla de Avila
    Kathy Terra
    Patrick Austin
    Thomas Jeffers
    Carey Escheik
    Pegah Golabi
    Rebecca Cable
    Manirath Srishord
    Chapy Venkatesan
    Linda Henry
    Lynn Gerber
    Zobair M. Younossi
    BMC Infectious Diseases, 22